TrialAnnals of surgical oncology2023
The Absence of Cancer in the Location of a Breast Tissue Marker After Neoadjuvant Chemotherapy may Predict Pathological Complete Response with High Accuracy: Results from a Phase II Trial.
Ayumi Kataoka et al.PubMed ↗Publisher ↗
No numbers read from the abstract.